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Research Center, Hopital Ste-Justine and Universite de Montreal, Montreal, Canada. Role of ions in Prolactin release.
To study the role of ions in the release of Prolactin (PRL), several experiments were performed utilizing dispersed pituitary cells obtained from adult, female Sprague-Dawley rats. All tests were done after a culture period of 5 days in multiwell Petri plates at 3 x 10 5 cells per well. Culture medium was Dulbecco's modified Eagle's medium (DHEM) supplemented with 10% horse serum. 2.5% fetal calf serum, non-essential amino-acids and antibiotics. PRL secretion was measured by specific RIA after 4 h of test incubation in various media at 37 0 in a C0 2 / ai r incubator. Basal PRL secretion in DMEM (154±12 ng/ml) was drastically reduced in a hypoosmolar. sodium deprived medium (48±4 ng/ml). remained low when NaCl was replaced by isoosmolar concentrations of glucose (33±2 ng/ml). and was restored by the addition of either sodium or choline 110 mH. When DA 10-llM was added to the medium with sodium, an 83% increment of PRL secretion was observed, while the neurotransmitter was completely inactive in absence of NaCl. DA 5 x 10-6M strongly inhibited PRL release in the presence of sodium but was inactive either in the absence of the ion or when the ion channel was blocked by tetrodotoxin (TTX). Baseline and DA-stimulated PRL release were also strongly inhibited by the addition to the medium of either Co++ (a calcium channel blocker) or TTX. These results indicate that a normal ionic charge in the medium is essential for baseline PRL secretion. while both sodium and calcium ions are necessary for DA control of hormone release. 
Idiopathic 01 is associated, by definition, with no obvious organic lesion. Despite negative clinical and neuraradialogical investigations, the question remains of the tumoral origin of the disease, .ainly if anterior pituitary dysfunction is de.anstrated. The purpose of this study was to evaluate the course and si~nificance of this association. 26 patients (6 familial) were investigated, with a fallowup of 4-20 yrs (x: 12.5 yrs) after onset of polyuria. Pneu.oencephalography (n: 27) and/or CT scan (n: 11) were nor-al.
GH deficiency was present in 10/26 cases. Recovery, nat related to puberty in all cases, was observed in 5 patients. TSH response to TRF (n: 17) was deficient (n: 3) or of the hypathala.ic type (n: 4). Puberty was normal in 17 cases, and abnormal in 2 cases (respectively precocious and slowly progressing). GH deficiency was isolated in 5 cases or ass~~ated with ACTH +TSH (n: 1), TSH (n: 1), ACTH (n: 3) abnarmal~t~es.
In conclusion : long term observation is necessary to ascerta~n the d~agnasis of idiopathic 01. Anterior pituitary deficiency may be associated, without any evidence of tumor. GH deficiency may be transient. These findings suggest that hypothalamic disturbances leading to idiopathic 01 involve more that the hypothalamic posterior pituitary system itself. Hunan growth holJlDne (1lGI) is camonly administrated by Lm. injections. 'nle high plrity of the present IlGI preparations makes s ,c , administration an attractive alternative enabling selfadministration. In this study time courses of plasma IlGI after s ,c ani Lm.injections of highly purIfLed IlGI (NanolJ1Dll R ) are described ani carpared to the diurnal plasma IlGI profile in eight oonnal children (11-14 years). Seven patients suffering fran idiopathic llGI~ficient dwarfisn (age 10-19~s) received Lm. ani s,c, injection of IlGI in the rroming (4IU/rn2) in raman order with an interval of one week. I.m. injections lead to a peak HGl concentration at 2 hours (mean 204,range 135-475 l'Xj!ml) with a return to baseline 8-10 hours after injection.Cbrrespondingly IlGl concentration peaked at 4 hrs (mean 38,range 15-68 l'Xj!ml)after s ,c, injection ani returned to baseline about 18 hours after injection. In a subsequent study on similar patients (n=7,age 10-19 years) IlGI (2IU/rn2) was injected s ,c, in the evenin:J.1lGI concentration peaked at 5 hours (mean 17,range 7-28 l'Xj!ml) ani returned to baseline 14 hours after injection.'1he results :lro.icate that absorption fran an Lm. depot is far too sb:>rt to give a P1Ysiological diurnal profile of IlGI in p1asna -even by daily aaninistration. Dept. of Pediatrics, University of Zurich, Switzerland "A-type" isolated growth honnone deficiency (IGHD). In 1970, we presented the "A-type" of autalOlllal raeeulve IGHD charocterlzed by early and ....ere growth retardation, typical face with vaulted farehead, a strong metabolic and g.-th retpanse ta exogenous hGH, and a tendency ta fonn high GH antibodies which abolish this effect.
Recentevents prompt us to report on these patients again: 1) Philippset 01 (abstr.Ped. Res. 1981) carried out restriction endonuclease studies In our original familyA, yielding abnonnal DNApatterns of the GH genes. In ather families with IGHD, they found a nonnal pattern. 2) One of our female patients of the same family (26 years, 118 em) gave birth ta a healthy girl (GA .w weeks, 2370 g, 43 em). GH antibodies were found not only in the mather (12 years after the end of hGH 1\) but aha In the newborn. Five manths later, na mare antibodies were detectable. 3) In anather family we succeeded for the first time to treat a 5 year-old boy with hGH aver a period of 1.5 years without the appearance of HG antibodies SO far. This Is in contrast to his 10 year-old brother previouslytreated with a different hGH preparation whodevelopped high titre, growth-Inhibiting GH antibodies. It appears thot certain hGH preparationsare talerated by th_ patients who presumably suffer from a prenatal GH deficiency which may couse a lack of immunotalerance for hGH. Supported by the Swiu Notional Science Foundation Grant No. 3.901.077 
